
No. of Pages: 109 | Report Code: TIPRE00024820 | Category: Life Sciences
No. of Pages: 109 | Report Code: TIPRE00024820 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Gastroparesis Market – By Type
1.3.2 APAC Gastroparesis Market – By Drug Class Type
1.3.3 APAC Gastroparesis Market – By Distribution Channel
1.3.4 APAC Gastroparesis Market – By Country
2. APAC Gastroparesis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Gastroparesis Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Gastroparesis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Diabetes Mellitus is Becoming More Common
5.1.2 Geriatric Population is Growing
5.2 Market Restraints
5.2.1 Adverse Effects of Gastroparesis Drugs
5.3 Market Opportunities
5.3.1 Research Funding on Rise
5.4 Future Trends
5.4.1 High Focus on Gastric Electrical Stimulation Therapy Research
5.5 Impact Analysis
6. Gastroparesis Market – APAC Analysis
6.1 APAC Gastroparesis Market Revenue Forecast and Analysis
7. APAC Gastroparesis Market Analysis – By Type
7.1 Overview
7.2 APAC Gastroparesis Market Revenue Share, by Type (2019 and 2027)
7.3 Idiopathic
7.3.1 Overview
7.3.2 Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Diabetic
7.4.1 Overview
7.4.2 Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Post-Surgical
7.5.1 Overview
7.5.2 Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8. APAC Gastroparesis Market Analysis – By Drug Class Type
8.1 Overview
8.2 APAC Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
8.3 Prokinetic Agents
8.3.1 Overview
8.3.2 Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Botulinum Toxin Injection
8.4.1 Overview
8.4.2 Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Antiemetic Agents
8.5.1 Overview
8.5.2 Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9. APAC Gastroparesis Market Analysis – By Distribution Channel
9.1 Overview
9.2 APAC Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
10. APAC Gastroparesis Market – Country Analysis
10.1 Overview
10.1.1 APAC: Gastroparesis Market, by Country, 2019 & 2027 (%)
10.1.2 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.2.1 China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.2.2 China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.2.3 China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.2.4 China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.3 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.4 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.5 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.7 Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Rest of APAC Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Rest of APAC Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Rest of APAC Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on APAC Gastroparesis Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Gastroparesis Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Gastroparesis Market, 2018-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Allergan Plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bausch Health Companies Inc. (Salix Pharmaceuticals)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Pfizer Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Ipca Laboratories Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 3. China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 9. India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of APAC Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of APAC Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of APAC Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. Recent Inorganic Growth Strategies in the Gastroparesis market
Table 20. Glossary of Terms, Gastroparesis Market
LIST OF FIGURES
Figure 1. APAC Gastroparesis Market Segmentation
Figure 2. APAC Gastroparesis Market Segmentation, By Country
Figure 3. APAC Gastroparesis Market Overview
Figure 4. Idiopathic Segment Held Largest Share of APAC Gastroparesis Market
Figure 5. India to Show Remarkable Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Gastroparesis Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. APAC Gastroparesis Market Revenue Share, by Type (2019 and 2027)
Figure 10. APAC Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. APAC Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. APAC Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. APAC Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. APAC Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
Figure 15. APAC Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. APAC Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. APAC Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. APAC Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 19. APAC Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. APAC Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. APAC Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. APAC: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Impact of COVID-19 Pandemic on Gastroparesis Market in APAC Countries
Figure 30. Growth Strategies in the Gastroparesis Market, 2018-2020